Co-Authors
This is a "connection" page, showing publications co-authored by Arjun Puranik and Patrick Lenehan.
Connection Strength
0.180
-
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. J Clin Invest. 2021 10 01; 131(19).
Score: 0.061
-
Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines. Med (N Y). 2021 Aug 13; 2(8):965-978.e5.
Score: 0.060
-
FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. Med (N Y). 2021 Aug 13; 2(8):979-992.e8.
Score: 0.060